Ocular Therapeutix Inc OCUL:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/14/21 EDT
14.81UNCH (UNCH)
Volume
11,524
Close
14.81quote price arrow down-0.16 (-1.07%)
Volume
739,272
52 week range
5.85 - 24.30

...

Loading . . .
  • Open15.08
  • Day High15.40
  • Day Low14.75
  • Prev Close14.97
  • 52 Week High24.30
  • 52 Week High Date12/16/20
  • 52 Week Low5.85
  • 52 Week Low Date05/21/20

Key Stats

  • Market Cap1.13B
  • Shares Out76.29M
  • 10 Day Average Volume1.65M
  • Dividend-
  • Dividend Yield-
  • Beta2.16
  • YTD % Change-28.45

KEY STATS

  • Open15.08
  • Day High15.40
  • Day Low14.75
  • Prev Close14.97
  • 52 Week High24.30
  • 52 Week High Date12/16/20
  • 52 Week Low5.85
  • 52 Week Low Date05/21/20
  • Market Cap1.13B
  • Shares Out76.29M
  • 10 Day Average Volume1.65M
  • Dividend-
  • Dividend Yield-
  • Beta2.16
  • YTD % Change-28.45

RATIOS/PROFITABILITY

  • EPS (TTM)-2.00
  • P/E (TTM)-7.40
  • Fwd P/E (NTM)-20.18
  • EBITDA (MRQ)-63.776M
  • ROE (MRQ)-360.15%
  • Revenue (MRQ)22.14M
  • Gross Margin (MRQ)90.26%
  • Net Margin (MRQ)-591.81%
  • Debt To Equity (MRQ)57.57%

EVENTS

  • Earnings Date08/05/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Ocular Therapeutix Inc

There is no recent news for this security.

Profile

MORE
Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the development, manufacturing and commercialization of therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology. Its lead product candidate, DEXTENZA (dexamethasone insert) for intracanalicular use, has completed Phase III clinical development for the treatment of ocular pain and inflammation following ophthalmic surgery. OTX-TP (travoprost insert) is in Phase III...
Charles Warden
Chairman
Antony Mattessich
President
Donald Notman Jr.
Chief Financial Officer
Address
24 Crosby Dr
Bedford, MA
01730-1402
United States

Top Peers

SYMBOLLASTCHG%CHG
ZGNX
Zogenix Inc
19.12-0.12-0.62%
OMER
Omeros Corp
18.20-0.13-0.71%
CSTL
Castle Biosciences Inc
55.17+5.10+10.19%
AERI
Aerie Pharmaceuticals Inc
17.41-0.46-2.57%
RLMD
Relmada Therapeutics Inc
33.83+0.33+0.99%